Protein changes in the retina following experimental retinal detachment in rabbits

Molecular Vision

Volumn 17, Issue , 2011, Pages 2634-2648

  Mandal, Nakul ^a,b,c   Lewis, Geoffrey P ^d   Fisher, Steven K ^d   Heegaard, Steffen ^a   Prause, Jan U ^a   la Cour, Morten ^a   Vorum, Henrik ^c   Honoré, Bent ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE SYNTHASE SUBUNIT BETA; ALBUMIN; ALPHA ENOLASE; FRUCTOSE BISPHOSPHATE ALDOLASE; GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE PROTEIN; MITOCHONDRIAL CREATINE KINASE; PROHIBITIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; TRANSDUCIN BETA 1; TUBULIN BETA 2C; UNCLASSIFIED DRUG; VIMENTIN;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; LIQUID CHROMATOGRAPHY; MICROGLIA; MOLECULAR WEIGHT; MUELLER CELL; NONHUMAN; PATHOPHYSIOLOGY; PHOTORECEPTOR CELL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEOMICS; RABBIT; RETINA DETACHMENT; RETINA DISEASE; SUBRETINAL FIBROSIS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; VITREORETINOPATHY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CHROMATOGRAPHY, LIQUID; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EYE PROTEINS; GENE EXPRESSION PROFILING; PROTEOMICS; RABBITS; RETINA; RETINAL DETACHMENT; TANDEM MASS SPECTROMETRY;

EID: 83055170882     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (114)

1. Wolfensberger TJ. Jules Gonin. Pioneer of retinal detachment surgery. Indian J Ophthalmol 2003; 51:303-8. [PMID: 14750617]
2. D'Amico DJ. Clinical practice. Primary retinal detachment. N Engl J Med 2008; 359:2346-54. [PMID: 19038880]
3. Charteris DG. Proliferative vitreoretinopathy: pathobiology, surgical management, and adjunctive treatment. Br J Ophthalmol 1995; 79:953-60. [PMID: 7488586]
4. Pastor JC, de la Rua ER, Martin F. Proliferative vitreoretinopathy: risk factors and pathobiology. Prog Retin Eye Res 2002; 21:127-44. [PMID: 11906814]
5. Fisher SK, Lewis GP. Cellular effects of detachment and reattachment on the neural retina and the retinal pigment epithelium. In: Ryan SJ, Hinton DR, Schachat AP, Wilkinson CP, editors. Retina. Vol 3. 4th ed. St Louis: Mosby; 2006. p. 1991-2012.
6. Machemer R, Aaberg TM, Freeman HM, Irvine AR, Lean JS, Michels RM. An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 1991; 112:159-65. [PMID: 1867299]
7. Anderson DH, Stern WH, Fisher SK, Erickson PA, Borgula GA. The onset of pigment epithelial proliferation after retinal detachment. Invest Ophthalmol Vis Sci 1981; 21:10-6. [PMID: 7251293]
8. Campochiaro PA, Jerdan JA, Glaser BM, Cardin A, Michels RG. Vitreous aspirates from patients with proliferative vitreoretinopathy stimulate retinal pigment epithelial cell migration. Arch Ophthalmol 1985; 103:1403-5. [PMID: 4038135]
9. Hiscott P, Sheridan C, Magee RM, Grierson I. Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res 1999; 18:167-90. [PMID: 9932282]
10. Tamiya S, Liu L, Kaplan HJ. Epithelial-mesenchymal transition and proliferation of retinal pigment epithelial cells initiated upon loss of cell-cell contact. Invest Ophthalmol Vis Sci 2010; 51:2755-63. [PMID: 20042656]
11. Kon CH, Occleston NL, Charteris D, Daniels J, Aylward GW, Khaw PT. A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1998; 39:1524-9. [PMID: 9660504]
12. Lewis GP, Guerin CJ, Anderson DH, Matsumoto B, Fisher SK. Rapid changes in the expression of glial cell proteins caused by experimental retinal detachment. Am J Ophthalmol 1994; 118:368-76. [PMID: 7916177]
13. Lewis GP, Betts KE, Sethi CS, Charteris DG, Lesnik-Oberstein SY, Avery RL, Fisher SK. Identification of ganglion cell neurites in human subretinal and epiretinal membranes. Br J Ophthalmol 2007; 91:1234-8. [PMID: 17108012]
14. Hiscott PS, Grierson I, Trombetta CJ, Rahi AH, Marshall J, McLeod D. Retinal and epiretinal glia-an immunohistochemical study. Br J Ophthalmol 1984; 68:698-707. [PMID: 6383462]
15. Lesnik Oberstein SY, Lewis GP, Chapin EA, Fisher SK. Ganglion cell neurites in human idiopathic epiretinal membranes. Br J Ophthalmol 2008; 92:981-5. [PMID: 18577651]
16. García-Arumí J, Corcostegui B, Tallada N. Subretinal membranes in proliferative vitreoretinopathy. An immunohistochemical study. Retina 1992; 12:S55-9. [PMID: 1280852]
17. Lewis GP, Linberg KA, Fisher SK. Neurite outgrowth from bipolar and horizontal cells after experimental retinal detachment. Invest Ophthalmol Vis Sci 1998; 39:424-34. [PMID: 9478003]
18. Anderson DH, Guerin CJ, Erickson PA, Stern WH, Fisher SK. Morphological recovery in the reattached retina. Invest Ophthalmol Vis Sci 1986; 27:168-83. [PMID: 3943943]
19. Machemer R. Pathogenesis and classification of massive periretinal proliferation. Br J Ophthalmol 1978; 62:737-47. [PMID: 102335]
20. Hiscott P, Hagan S, Heathcote L, Sheridan CM, Groenewald CP, Grierson I, Wong D, Paraoan L. Pathobiology of epiretinal and subretinal membranes: possible roles for the matricellular proteins thrombospondin 1 and osteonectin (SPARC). Eye (Lond) 2002; 16:393-403. [PMID: 12101446]
21. Charteris DG. Growth factors in proliferative vitreoretinopathy. Br J Ophthalmol 1998; 82:106. [PMID: 9613372]
22. Wiedemann P, Hilgers RD, Bauer P, Heimann K. Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. Am J Ophthalmol 1998; 126:550-9. [PMID: 9780100]
23. Charteris DG, Aylward GW, Wong D, Groenewald C, Asaria RH, Bunce C. A randomized controlled trial of combined 5-fluorouracil and low-molecular-weight heparin in management of established proliferative vitreoretinopathy. Ophthalmology 2004; 111:2240-5. [PMID: 15582080]
24. Wickham L, Bunce C, Wong D, McGurn D, Charteris DG. Randomized controlled trial of combined 5-Fluorouracil and low-molecular-weight heparin in the management of unselected rhegmatogenous retinal detachments undergoing primary vitrectomy. Ophthalmology 2007; 114:698-704. [PMID: 17398320]
25. Leiderman YI, Miller JW. Proliferative vitreoretinopathy: pathobiology and therapeutic targets. Semin Ophthalmol 2009; 24:62-9. [PMID: 19373688]
26. Lewis GP, Charteris DG, Sethi CS, Fisher SK. Animal models of retinal detachment and reattachment: identifying cellular events that may affect visual recovery. Eye (Lond) 2002; 16:375-87. [PMID: 12101444]
27. Fisher SK, Lewis GP, Linberg KA, Verardo MR. Cellular remodeling in mammalian retina: results from studies of experimental retinal detachment. Prog Retin Eye Res 2005; 24:395-431. [PMID: 15708835]
28. Sethi CS, Lewis GP, Fisher SK, Leitner WP, Mann DL, Luthert PJ, Charteris DG. Glial remodeling and neural plasticity in human retinal detachment with proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 2005; 46:329-42. [PMID: 15623793]
29. Wilson DJ, Green WR. Histopathologic study of the effect of retinal detachment surgery on 49 eyes obtained post mortem. Am J Ophthalmol 1987; 103:167-79. [PMID: 3492917]
30. Chang CJ, Lai WW, Edward DP, Tso MO. Apoptotic photoreceptor cell death after traumatic retinal detachment in humans. Arch Ophthalmol 1995; 113:880-6. [PMID: 7605279]
31. Wickham L, Sethi CS, Lewis GP, Fisher SK, McLeod DC, Charteris DG. Glial and neural response in short-term human retinal detachment. Arch Ophthalmol 2006; 124:1779-82. [PMID: 17159042]
32. Mandal N, Heegaard S, Prause JU, Honoré B, Vorum H. Ocular proteomics with emphasis on two-dimensional gel electrophoresis and mass spectrometry. Biol Proced Online 2009; 12:56-88. [PMID: 21406065]
33. Mortz E, Krogh TN, Vorum H, Gorg A. Improved silver staining protocols for high sensitivity protein identification using matrix-assisted laser desorption/ionization-time of flight analysis. Proteomics 2001; 1:1359-63. [PMID: 11922595]
34. Honoré B, Buus S, Claesson MH. Identification of differentially expressed proteins in spontaneous thymic lymphomas from knockout mice with deletion of p53. Proteome Sci 2008; 6:18. [PMID: 18544163]
35. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probabilitybased protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999; 20:3551-67. [PMID: 10612281]
36. Lewis GP, Matsumoto B, Fisher SK. Changes in the organization and expression of cytoskeletal proteins during retinal degeneration induced by retinal detachment. Invest Ophthalmol Vis Sci 1995; 36:2404-16. [PMID: 7591630]
37. Berglin L, Algvere PV, Seregard S. Photoreceptor decay over time and apoptosis in experimental retinal detachment. Graefes Arch Clin Exp Ophthalmol 1997; 235:306-12. [PMID: 9176679]
38. Faude F, Francke M, Makarov F, Schuck J, Gärtner U, Reichelt W, Wiedemann P, Wolburg H, Reichenbach A. Experimental retinal detachment causes widespread and multilayered degeneration in rabbit retina. J Neurocytol 2001; 30:379-90. [PMID: 11951049]
39. Yu DY, Cringle SJ. Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease. Prog Retin Eye Res 2001; 20:175-208. [PMID: 11173251]
40. Verardo MR, Lewis GP, Takeda M, Linberg KA, Byun J, Luna G, Wilhelmsson U, Pekny M, Chen DF, Fisher SK. Abnormal reactivity of Müller cells after retinal detachment in mice deficient in GFAP and vimentin. Invest Ophthalmol Vis Sci 2008; 49:3659-65. [PMID: 18469190]
41. Lundkvist A, Reichenbach A, Betsholtz C, Carmeliet P, Wolburg H, Pekny M. Under stress, the absence of intermediate filaments from Müller cells in the retina has structural and functional consequences. J Cell Sci 2004; 117:3481-8. [PMID: 15226376]
42. Lewis GP, Sethi CS, Linberg KA, Charteris DG, Fisher SK. Experimental retinal reattachment: a new perspective. Mol Neurobiol 2003; 28:159-75. [PMID: 14576454]
43. Kim JW, Dang CV. Multifaceted roles of glycolytic enzymes. Trends Biochem Sci 2005; 30:142-50. [PMID: 15752986]
44. Linsenmeier RA, Padnick-Silver L. Metabolic dependence of photoreceptors on the choroid in the normal and detached retina. Invest Ophthalmol Vis Sci 2000; 41:3117-23. [PMID: 10967072]
45. Aaronson RM, Graven KK, Tucci M, McDonald RJ, Farber HW. Non-neuronal enolase is an endothelial hypoxic stress protein. J Biol Chem 1995; 270:27752-7. [PMID: 7499243]
46. Pancholi V. Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci 2001; 58:902-20. [PMID: 11497239]
47. Jiang BH, Agani F, Passaniti A, Semenza GL. V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression. Cancer Res 1997; 57:5328-35. [PMID: 9393757]
48. Arjamaa O, Nikinmaa M. Oxygen-dependent diseases in the retina: role of hypoxia-inducible factors. Exp Eye Res 2006; 83:473-83. [PMID: 16750526]
49. Semenza GL, Jiang BH, Leung SW, Passantino R, Concordet JP, Maire P, Giallongo A. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxiainducible factor 1. J Biol Chem 1996; 271:32529-37. [PMID: 8955077]
50. Semenza GL, Roth PH, Fang HM, Wang GL. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxiainducible factor 1. J Biol Chem 1994; 269:23757-63. [PMID: 8089148]
51. Semenza GL. Regulation of oxygen homeostasis by hypoxiainducible factor 1. Physiology (Bethesda) 2009; 24:97-106. [PMID: 19364912]
52. Winkler BS, Arnold MJ, Brassell MA, Puro DG. Energy metabolism in human retinal Müller cells. Invest Ophthalmol Vis Sci 2000; 41:3183-90. [PMID: 10967082]
53. Poitry-Yamate CL, Poitry S, Tsacopoulos M. Lactate released by Müller glial cells is metabolized by photoreceptors from mammalian retina. J Neurosci 1995; 15:5179-91. [PMID: 7623144]
54. Newman EA. Distribution of potassium conductance in mammalian Müller (glial) cells: a comparative study. J Neurosci 1987; 7:2423-32. [PMID: 2441009]
55. Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF. Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. Biochemistry 1991; 30:1682-91. [PMID: 1847072]
56. Vassalli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest 1991; 88:1067-72. [PMID: 1833420]
57. Lijnen HR. Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry (Mosc) 2002; 67:92-8. [PMID: 11841344]
58. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 1997; 91:439-42. [PMID: 9390552]
59. Chapman HA, Wei Y. Protease crosstalk with integrins: the urokinase receptor paradigm. Thromb Haemost 2001; 86:124-9. [PMID: 11486997]
60. Feo S, Arcuri D, Piddini E, Passantino R, Giallongo A. ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoterbinding protein 1 (MBP-1). FEBS Lett 2000; 473:47-52. [PMID: 10802057]
61. Subramanian A, Miller DM. Structural analysis of alphaenolase. Mapping the functional domains involved in downregulation of the c-myc protooncogene. J Biol Chem 2000; 275:5958-65. [PMID: 10681589]
62. O'Reilly G, Clarke F. Identification of an actin binding region in aldolase. FEBS Lett 1993; 321:69-72. [PMID: 8467913]
63. Kusakabe T, Motoki K, Hori K. Mode of interactions of human aldolase isozymes with cytoskeletons. Arch Biochem Biophys 1997; 344:184-93. [PMID: 9244396]
64. Waingeh VF, Gustafson CD, Kozliak EI, Lowe SL, Knull HR, Thomasson KA. Glycolytic enzyme interactions with yeast and skeletal muscle F-actin. Biophys J 2006; 90:1371-84. [PMID: 16326908]
65. Anderson B Jr, Saltzman HA. Retinal Oxygen Utilization Measured by Hyperbaric Blackout. Arch Ophthalmol 1964; 72:792-5. [PMID: 14205438]
66. Ames A 3rd. Energy requirements of CNS cells as related to their function and to their vulnerability to ischemia: a commentary based on studies on retina. Can J Physiol Pharmacol 1992; 70:S158-64. [PMID: 1295666]
67. Mervin K, Valter K, Maslim J, Lewis G, Fisher S, Stone J. Limiting photoreceptor death and deconstruction during experimental retinal detachment: the value of oxygen supplementation. Am J Ophthalmol 1999; 128:155-64. [PMID: 10458170]
68. Kucharczyk R, Zick M, Bietenhader M, Rak M, Couplan E, Blondel M, Caubet SD, di Rago JP. Mitochondrial ATP synthase disorders: molecular mechanisms and the quest for curative therapeutic approaches. Biochim Biophys Acta 2009; 1793:186-99. [PMID: 18620007]
69. Uga S. Smelser. Comparative study of the fine structure of retinal Müller cells in various vertebrates. Invest Ophthalmol 1973; 12:434-48. [PMID: 4541022]
70. Hoang QV, Linsenmeier RA, Chung CK, Curcio CA. Photoreceptor inner segments in monkey and human retina: mitochondrial density, optics, and regional variation. Vis Neurosci 2002; 19:395-407. [PMID: 12511073]
71. Lewis GP, Talaga KC, Linberg KA, Avery RL, Fisher SK. The efficacy of delayed oxygen therapy in the treatment of experimental retinal detachment. Am J Ophthalmol 2004; 137:1085-95. [PMID: 15183794]
72. Andres RH, Ducray AD, Schlattner U, Wallimann T, Widmer HR. Functions and effects of creatine in the central nervous system. Brain Res Bull 2008; 76:329-43. [PMID: 18502307]
73. Hemmer W, Riesinger I, Wallimann T, Eppenberger HM, Quest AF. Brain-type creatine kinase in photoreceptor cell outer segments: role of a phosphocreatine circuit in outer segment energy metabolism and phototransduction. J Cell Sci 1993; 106:671-83. [PMID: 8282772]
74. Meyer LE, Machado LB, Santiago AP, da-Silva WS, De Felice FG, Holub O, Oliveira MF, Galina A. Mitochondrial creatine kinase activity prevents reactive oxygen species generation: antioxidant role of mitochondrial kinase-dependent ADP recycling activity. J Biol Chem 2006; 281:37361-71. [PMID: 17028195]
75. Dolder M, Wendt S, Wallimann T. Mitochondrial creatine kinase in contact sites: interaction with porin and adenine nucleotide translocase, role in permeability transition and sensitivity to oxidative damage. Biol Signals Recept 2001; 10:93-111. [PMID: 11223643]
76. Dolder M, Walzel B, Speer O, Schlattner U, Wallimann T. Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation. J Biol Chem 2003; 278:17760-6. [PMID: 12621025]
77. Green DR, Kroemer G. The pathophysiology of mitochondrial cell death. Science 2004; 305:626-9. [PMID: 15286356]
78. Ow YP, Green DR, Hao Z, Mak TW. Cytochrome c: functions beyond respiration. Nat Rev Mol Cell Biol 2008; 9:532-42. [PMID: 18568041]
79. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995; 15:961-73. [PMID: 7576644]
80. Cook B, Lewis GP, Fisher SK, Adler R. Apoptotic photoreceptor degeneration in experimental retinal detachment. Invest Ophthalmol Vis Sci 1995; 36:990-6. [PMID: 7730033]
81. Quinlan GJ, Martin GS, Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology 2005; 41:1211-9. [PMID: 15915465]
82. Andersen JT, Sandlie I. The versatile MHC class I-related FcRn protects IgG and albumin from degradation: implications for development of new diagnostics and therapeutics. Drug Metab Pharmacokinet 2009; 24:318-32. [PMID: 19745559]
83. Bento-Abreu A, Velasco A, Polo-Hernández E, Lillo C, Kozyraki R, Tabernero A, Medina JM. Albumin endocytosis via megalin in astrocytes is caveola-and Dab-1 dependent and is required for the synthesis of the neurotrophic factor oleic acid. J Neurochem 2009; 111:49-60. [PMID: 19656258]
84. Sabah JR, Davidson H, McConkey EN, Takemoto L. In vivo passage of albumin from the aqueous humor into the lens. Mol Vis 2004; 10:254-9. [PMID: 15073582]
85. Pederson JE, Toris CB. Experimental retinal detachment. IX. Aqueous, vitreous, and subretinal protein concentrations. Arch Ophthalmol 1985; 103:835-6. [PMID: 4004625]
86. Adler AJ, Severin KM. Proteins of the bovine interphotoreceptor matrix: tissues of origin. Exp Eye Res 1981; 32:755-69. [PMID: 7250225]
87. Takeuchi A, Kricorian G, Yao XY, Kenny JW, Marmor MF. The rate and source of albumin entry into saline-filled experimental retinal detachments. Invest Ophthalmol Vis Sci 1994; 35:3792-8. [PMID: 7928176]
88. Kaur C, Foulds WS, Ling EA. Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res 2008; 27:622-47. [PMID: 18940262]
89. Little BC, Ambrose VM. Blood-aqueous barrier breakdown associated with rhegmatogenous retinal detachment. Eye (Lond) 1991; 5:56-62. [PMID: 2060672]
90. Nagasaki H, Shinagawa K, Mochizuki M. Risk factors for proliferative vitreoretinopathy. Prog Retin Eye Res 1998; 17:77-98. [PMID: 9537796]
91. Adler AJ, Edwards RB. Human interphotoreceptor matrix contains serum albumin and retinol-binding protein. Exp Eye Res 2000; 70:227-34. [PMID: 10655149]
92. Yoshida K, Seto-Ohshima A, Sinohara H. Sequencing of cDNA encoding serum albumin and its extrahepatic synthesis in the Mongolian gerbil, Meriones unguiculatus. DNA Res 1997; 4:351-4. [PMID: 9455485]
93. Sabah J, McConkey E, Welti R, Albin K, Takemoto LJ. Role of albumin as a fatty acid carrier for biosynthesis of lens lipids. Exp Eye Res 2005; 80:31-6. [PMID: 15652523]
94. Ulrich JN, Spannagl M, Kampik A, Gandorfer A. Components of the fibrinolytic system in the vitreous body in patients with vitreoretinal disorders. Clin Experiment Ophthalmol 2008; 36:431-6. [PMID: 18939350]
95. Bolitho C, Bayl P, Hou JY, Lynch G, Hassel AJ, Wall AJ, Zoellner H. The anti-apoptotic activity of albumin for endothelium is mediated by a partially cryptic protein domain and reduced by inhibitors of G-coupled protein and PI-3 kinase, but is independent of radical scavenging or bound lipid. J Vasc Res 2007; 44:313-24. [PMID: 17438360]
96. Erkan E, Devarajan P, Schwartz GJ. Mitochondria are the major targets in albumin-induced apoptosis in proximal tubule cells. J Am Soc Nephrol 2007; 18:1199-208. [PMID: 17360944]
97. Iglesias J, Abernethy VE, Wang Z, Lieberthal W, Koh JS, Levine JS. Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROS. Am J Physiol 1999; 277:F711-22. [PMID: 10564234]
98. Zacks DN, Han Y, Zeng Y, Swaroop A. Activation of signaling pathways and stress-response genes in an experimental model of retinal detachment. Invest Ophthalmol Vis Sci 2006; 47:1691-5. [PMID: 16565410]
99. Hollborn M, Francke M, Iandiev I, Bühner E, Foja C, Kohen L, Reichenbach A, Wiedemann P, Bringmann A, Uhlmann S. Early activation of inflammation-and immune responserelated genes after experimental detachment of the porcine retina. Invest Ophthalmol Vis Sci 2008; 49:1262-73. [PMID: 18326757]
100. Carter-Dawson L, Zhang Y, Harwerth RS, Rojas R, Dash P, Zhao XC, WoldeMussie E, Ruiz G, Chuang A, Dubinsky WP, Redell JB. Elevated albumin in retinas of monkeys with experimental glaucoma. Invest Ophthalmol Vis Sci 2010; 51:952-9. [PMID: 19797225]
101. Anderson DH, Neitz J, Saari JC, Kaska DD, Fenwick J, Jacobs GH, Fisher SK. Retinoid-binding proteins in cone-dominant retinas. Invest Ophthalmol Vis Sci 1986; 27:1015-26. [PMID: 3721781]
102. Merkwirth C, Langer T. Prohibitin function within mitochondria: essential roles for cell proliferation and cristae morphogenesis. Biochim Biophys Acta 2009; 1793:27-32. [PMID: 18558096]
103. Mishra S, Murphy LC, Nyomba BL, Murphy LJ. Prohibitin: a potential target for new therapeutics. Trends Mol Med 2005; 11:192-7. [PMID: 15823758]
104. Nijtmans LG, de Jong L, Artal Sanz M, Coates PJ, Berden JA, Back JW, Muijsers AO, van der Spek H, Grivell LA. Prohibitins act as a membrane-bound chaperone for the stabilization of mitochondrial proteins. EMBO J 2000; 19:2444-51. [PMID: 10835343]
105. Mishra S, Murphy LC, Murphy LJ. The prohibitins: emerging roles in diverse functions. J Cell Mol Med 2006; 10:353-63. [PMID: 16796804]
106. Merkwirth C, Dargazanli S, Tatsuta T, Geimer S, Löwer B, Wunderlich FT, von Kleist-Retzow JC, Waisman A, Westermann B, Langer T. Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria. Genes Dev 2008; 22:476-88. [PMID: 18281461]
107. Fusaro G, Dasgupta P, Rastogi S, Joshi B, Chellappan S. Prohibitin induces the transcriptional activity of p53 and is exported from the nucleus upon apoptotic signaling. J Biol Chem 2003; 278:47853-61. [PMID: 14500729]
108. Wang S, Fusaro G, Padmanabhan J, Chellappan SP. Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression. Oncogene 2002; 21:8388-96. [PMID: 12466959]
109. Theiss AL, Vijay-Kumar M, Obertone TS, Jones DP, Hansen JM, Gewirtz AT, Merlin D, Sitaraman SV. Prohibitin is a novel regulator of antioxidant response that attenuates colonic inflammation in mice. Gastroenterology 2009; 137:199-208. [PMID: 19327358]
110. McClung JK, Jupe ER, Liu XT, Dell'Orco RT. Prohibitin: potential role in senescence, development, and tumor suppression. Exp Gerontol 1995; 30:99-124. [PMID: 8591812]
111. Yau KW. Phototransduction mechanism in retinal rods and cones. The Friedenwald Lecture. Invest Ophthalmol Vis Sci 1994; 35:9-32. [PMID: 7507907]
112. Fu Y, Yau KW. Phototransduction in mouse rods and cones. Pflugers Arch 2007; 454:805-19. [PMID: 17226052]
113. Hao W, Wenzel A, Obin MS, Chen CK, Brill E, Krasnoperova NV, Eversole-Cire P, Kleyner Y, Taylor A, Simon MI, Grimm C, Remé CE, Lem J. Evidence for two apoptotic pathways in light-induced retinal degeneration. Nat Genet 2002; 32:254-60. [PMID: 12219089]
114. Kong L, Li F, Soleman CE, Li S, Elias RV, Zhou X, Lewis DA, McGinnis JF, Cao W. Bright cyclic light accelerates photoreceptor cell degeneration in tubby mice. Neurobiol Dis 2006; 21:468-77. [PMID: 16216520]